MASTERS PARKWAY
Live / Registered — Registered (as of 21 Jul 2026)
What this means for you
Registered since 21 Jul 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Jul 2032: the §71 affidavit of use).
Record
- Serial number
- 79427708
- Registration number
- 8350084
- Mark type
- Word mark
- Filed
- 27 May 2025
- Published for opposition
- 02 Jun 2026
- Registered
- 21 Jul 2026
- Next maintenance filing
- §71 affidavit of use, due by 21 Jul 2032 (grace period to 21 Jan 2033)
- Attorney of record
- Ee Ming T. Bahk
Goods and services
- Class 010 — Medical apparatus: Medical guidewires and structural parts therefor; interventional radiology (IVR) medical guidewires; percutaneous transluminal coronary angioplasty (PTCA) medical guidewires; medical spring guidewires; medical plastic clad guidewires; medical catheters and structural parts therefor; percutaneous transluminal coronary angioplasty (PTCA) guiding catheters; percutaneous transluminal coronary angioplasty (PTCA) balloon catheters; angiographic catheters; micro catheters; occlusion catheters; ablation catheters; atherectomy catheters; stents and structural parts therefor
Owner
Prosecution history
- 21 Oct 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 21 Jul 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Jul 2026 — REGISTERED-PRINCIPAL REGISTER
- 02 Jun 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Jun 2026 — PUBLISHED FOR OPPOSITION
- 27 May 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 May 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Nov 2025 — REFUSAL PROCESSED BY IB
- 08 Nov 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 08 Nov 2025 — REFUSAL PROCESSED BY MPU
- 19 Sept 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 18 Sept 2025 — NON-FINAL ACTION WRITTEN